We report a 45 year-old woman who had bilateral breast masses with extradural involvement. Pathologic report revealed malignant high-grade lymphoblastic lymphoma. Systemic chemotherapy was performed but 3 months later, lesions indicating relapse in bone and breast re-appeared. She received salvage chemotherapy, but 4 months after that she was expired.
INTRODUCTION
Lymphoblastic neoplasms, which may present as leukemia and/or lymphoma, are divided into two categories (1): Precursor T-cell lymphoblastic leukemia/lymphoma (precursor T-LBL) and Precursor Bcell ALL/LBL. Primary breast involvement with lymphoma (PBL) is very rare (2) . It means that less than one percent of all lymphoma cases are PBL (3) . PBL clinically, radiologically, and morphologically is similar to both benign and malignant conditions. We report a case of breast lymphoblastic lymphoma and discuss her diagnosis and management. To date, PBL has a poor prognosis; its therapeutic strategy is controversial and not completely confirmed.
CASE SUMMARIES
A 45 year-old woman with 6 months history of low back pain, weight loss, night sweat, fever and galactorrhea was referred to our center. Physical examination revealed multiple and palpable masses in both breasts and galactorrhea without peripheral lymphadenopathy. The rest of physical examination was unremarkable.
Ultrasonographic evaluation revealed lobular-shaped, partly ill-defined hypoechoic masses with 2-7 cm suggested Maltoma (Figure 1 ). In the setting of lymphoma staging, bone marrow aspiration and biopsy were performed and bone marrow involvement was highly suspected. Central nervous system involvement was ruled out by lumbar puncture (LP). cycles. Unfortunately, she was expired after 4 months.
DISCUSSION
As first described in 1959 (7), breast lymphomas are rare and include 0.04 to 0.5% of all breast malignancies (8) .
Breast involvement by lymphoma cells can be localized to 
CONCLUSION
This case highlights the atypical presentation of lymphoma mimicking an inflammatory breast cancer or other neoplasms presenting as bilateral breast masses. Core biopsy of the breast lesion will be helpful, and BMT is strongly recommended due to poor prognosis. Finally, we believe that the approach to breast lymphoma should be similar to that of the equivalent types presenting elsewhere.
